In addition, BLCAP represented a negative correlation with tumor progression by comparing its expression pattern in different grades and stages of bladder cancer and breast cancer, suggesting that it might be of value as a biomarker and providing a new perspective for the clinical application of this protein [7, 8]. This evidence concerns the gene BLCAP and urinary bladder carcinoma.